ARCHIVES

Tamoxifin Benefits Outweigh Risks, NSABP Study Finds

This article is from The Cancer Letter archive.

Vol. 20 No. 12 | March 23, 1994

Download PDF Visit The Full Archive

Related Articles

CCOP Letters Of Intent Reach 232; Frelick Experts 80-90 Percent Of them To Qualify For Applications

September 3, 1982

NIH Selects 16 Clinical Centers for Women’s Health Initiative

April 9, 1993

Duke Tells ACS The Check for $437,400 Is In The Mail

December 10, 2010

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014